Just reinforcing the very important issue when it comes to Bio startups.  That's all.

BTI is a long way off from proving itself. And it will take money to do it. For example, RVX had Eastern Capital (Ken Dart) believing in it, followed by Shenzen Hepalink (Li Li). Perhaps if it wasn't for them, RVX would not be where it is today. BTI needs someone similar to help it along the way. It will make it easier for Mark Day knowing the funds are there when needed.

IMO...Koo